BBBT (Black Bird Biotech) Pretax Margin %: -3,275.00% (As of Sep. 2023)


What is Black Bird Biotech Pretax Margin %?

Black Bird Biotech BBBT -99.00% Pretax Margin % is -3,275.00% as of Sep. 2023.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Black Bird Biotech's Pre-Tax Income for the three months ended in Sep. 2023 was $-0.13 Mil. Black Bird Biotech's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Black Bird Biotech's pretax margin for the quarter that ended in Sep. 2023 was -3,275.00%.

The historical rank and industry rank for Black Bird Biotech's Pretax Margin % or its related term are showing as below:


BBBT's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.295
* Ranked among companies with meaningful Pretax Margin % only.

Black Bird Biotech  (OTCPK:BBBT) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Black Bird Biotech Pretax Margin % Related Terms

Black Bird Biotech Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Black Bird Biotech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Black Bird Biotech Pretax Margin % Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1,189.66 -1,741.35 -1,998.80

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -865.38 -2,008.33 -3,814.29 -1,515.38 -3,275.00

BBBT vs BLMS, INLB, CENBF: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Black Bird Biotech Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's Pretax Margin % falls into.


Black Bird Biotech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Black Bird Biotech's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.659/0.083
=-1,998.80 %

Black Bird Biotech's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.131/0.004
=-3,275.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -3,275.00% mean?
Black Bird Biotech (BBBT) has a Pretax Margin % of -3,275.00% as of Sep. 2023. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Black Bird Biotech and its competitors.
Is Black Bird Biotech's Pretax Margin % too high?
Black Bird Biotech's current Pretax Margin % is -3,275.00%.
How does Black Bird Biotech's Pretax Margin % compare to BLMS and INLB?
Black Bird Biotech's Pretax Margin % of -3,275.00% can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Black Bird Biotech and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Black Bird Biotech's current Pretax Margin % is -3,275.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Black Bird Biotech stock overvalued right now?
Black Bird Biotech (BBBT) has a current Pretax Margin % of -3,275.00%. The current Pretax Margin % is -3,275.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Black Bird Biotech (BBBT), the current Pretax Margin % is -3,275.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Black Bird Biotech Business Description

Address 2801 E Camelback Road, Suite 200, Phoenix, AZ, USA, 85016
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.